Oncolys BioPharma Inc (4588) - Financial and Strategic SWOT Analysis Review

  • ID: 4285065
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OBP-801, OBP-601, OBP-AI-001 and OBP-AI-002. Oncolys offers diagnostic pipeline such as OBP-401 and OBP-1101. Oncolys research and develops oncolytic virus drugs for infectious diseases, molecular targeted anti-cancer drugs and tumor diagnostic agents. The company also provides consulting services for development of biotechnology drugs. It operates through its offices located in Tokyo, Kobe and Okayama. Oncolys is headquartered in Tokyo, Japan.

Oncolys BioPharma Inc Key Recent Developments

Jul 15, 2017: Oncolys BioPharma: Announcement of Financial Forecast for the First Half of the Fiscal Year Ending December 31, 2016

This comprehensive SWOT profile of Oncolys BioPharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Oncolys BioPharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Oncolys BioPharma Inc - Key Information
  • Oncolys BioPharma Inc - Overview
  • Oncolys BioPharma Inc - Key Employees
  • Oncolys BioPharma Inc - Key Employee Biographies
  • Oncolys BioPharma Inc - Key Operational Heads
  • Oncolys BioPharma Inc - Major Products and Services
  • Oncolys BioPharma Inc - History
  • Oncolys BioPharma Inc - Company Statement
  • Oncolys BioPharma Inc - Locations And Subsidiaries
  • Oncolys BioPharma Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Oncolys BioPharma Inc - Business Description
  • Oncolys BioPharma Inc - Corporate Strategy
  • Oncolys BioPharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Oncolys BioPharma Inc - Strengths
  • Oncolys BioPharma Inc - Weaknesses
  • Oncolys BioPharma Inc - Opportunities
  • Oncolys BioPharma Inc - Threats
  • Oncolys BioPharma Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Oncolys BioPharma Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Oncolys BioPharma Inc, Key Information
  • Oncolys BioPharma Inc, Key Ratios
  • Oncolys BioPharma Inc, Share Data
  • Oncolys BioPharma Inc, Major Products and Services
  • Oncolys BioPharma Inc, History
  • Oncolys BioPharma Inc, Key Employees
  • Oncolys BioPharma Inc, Key Employee Biographies
  • Oncolys BioPharma Inc, Key Operational Heads
  • Oncolys BioPharma Inc, Other Locations
  • Oncolys BioPharma Inc, Subsidiaries
  • Oncolys BioPharma Inc, Key Manufacturing facilities
  • Oncolys BioPharma Inc, Key Competitors
  • Oncolys BioPharma Inc, SWOT Analysis
  • Oncolys BioPharma Inc, Ratios based on current share price
  • Oncolys BioPharma Inc, Annual Ratios
  • Oncolys BioPharma Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Oncolys BioPharma Inc, Performance Chart
  • Oncolys BioPharma Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll